In this 2-minute audio snippet, Silja Chouquet
, Owner at whydot GmbH, suggests that pharmaceutical companies should stop trying to market brands via Twitter and focus on using it to support patients.
Silja was speaking at "The Future of Branding is #Now" 6th Ideagoras-BBVA International Conference on Innovation and Collaborative Branding (November 6, 2014).
Silja's presentation - "Pharma's DNA on Twitter" - is embedded below. It contrasts Twitter use by Novartis and Boehringer Ingelheim: